JP2024534667A5 - - Google Patents
Info
- Publication number
- JP2024534667A5 JP2024534667A5 JP2024519557A JP2024519557A JP2024534667A5 JP 2024534667 A5 JP2024534667 A5 JP 2024534667A5 JP 2024519557 A JP2024519557 A JP 2024519557A JP 2024519557 A JP2024519557 A JP 2024519557A JP 2024534667 A5 JP2024534667 A5 JP 2024534667A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- rest
- neurons
- variant
- glial cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111158620.4A CN115887655B (zh) | 2021-09-30 | 2021-09-30 | 直接转分化治疗神经系统疾病 |
| CN202111158620.4 | 2021-09-30 | ||
| PCT/CN2022/123409 WO2023051802A1 (zh) | 2021-09-30 | 2022-09-30 | 直接转分化治疗神经系统疾病 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534667A JP2024534667A (ja) | 2024-09-20 |
| JP2024534667A5 true JP2024534667A5 (enExample) | 2025-10-08 |
Family
ID=85750328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024519557A Pending JP2024534667A (ja) | 2021-09-30 | 2022-09-30 | 神経系疾患の直接分化転換治療 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250115650A1 (enExample) |
| EP (1) | EP4410296A4 (enExample) |
| JP (1) | JP2024534667A (enExample) |
| KR (1) | KR20240082366A (enExample) |
| CN (3) | CN115887655B (enExample) |
| AU (1) | AU2022357103A1 (enExample) |
| CA (1) | CA3233534A1 (enExample) |
| WO (1) | WO2023051802A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4692360A1 (en) * | 2023-03-30 | 2026-02-11 | Shanghai Genemagic Biosciences Co., Ltd. | Expression vector and composition for treating nervous system diseases |
| WO2025173411A1 (ja) * | 2024-02-14 | 2025-08-21 | 国立大学法人筑波大学 | 網膜神経節細胞分化誘導用キット、医薬組成物及び緑内障モデル |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2774698B1 (fr) * | 1998-02-12 | 2002-03-01 | Rhone Poulenc Rorer Sa | Utilisation d'elements de regulation negative pour l'expression neurospecifique de transgenes |
| ITVA20060041A1 (it) * | 2006-07-05 | 2008-01-06 | Dialectica Srl | Uso di composti derivati amminotiazolici, di loro composizioni farmaceutiche, nel trattamento di malattie caratterizzate dalla anormale repressione della trascrizione genica, particolarmente il morbo di huntington |
| WO2009058014A2 (en) * | 2007-11-02 | 2009-05-07 | Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg | Polypeptides involved in neuronal regeneration-associated gene expression |
| WO2011099502A1 (ja) * | 2010-02-10 | 2011-08-18 | 公立大学法人横浜市立大学 | 神経選択的転写抑制因子NRSFに特異的に結合するmSin3B に結合する化合物の利用 |
| WO2014071157A1 (en) * | 2012-11-01 | 2014-05-08 | The Regents Of The University Of California | Methods for engineering non-neuronal cells into neurons and using newly engineered neurons to treat neurodegenerative diseases |
| WO2016019315A2 (en) * | 2014-08-01 | 2016-02-04 | Oregon Health & Science University | Methods and compositions useful in manipulating the stability of re1 silencing transcription factor |
| EP3622057A1 (en) * | 2017-05-12 | 2020-03-18 | New York Stem Cell Foundation, Inc. | Systems |
| JP2021520200A (ja) * | 2018-04-11 | 2021-08-19 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｌｉｆｏｒｎｉａ | 非神経細胞のニューロンへの再プログラミング、及び神経変性疾患または障害を治療するための方法と組成物 |
| JP7555542B2 (ja) * | 2018-06-18 | 2024-09-25 | ユニバーシティー オブ ロチェスター | 統合失調症及び他の神経精神障害の治療方法 |
| JP7699588B2 (ja) * | 2019-11-22 | 2025-06-27 | アルカメナ・ステム・セル・セラピューティクス、エルエルシー | Ｒｅ１サイレンシング転写因子標的遺伝子を抑制解除する組成物 |
-
2021
- 2021-09-30 CN CN202111158620.4A patent/CN115887655B/zh active Active
- 2021-09-30 CN CN202510816959.0A patent/CN120754249A/zh active Pending
-
2022
- 2022-09-30 AU AU2022357103A patent/AU2022357103A1/en active Pending
- 2022-09-30 US US18/697,216 patent/US20250115650A1/en active Pending
- 2022-09-30 CA CA3233534A patent/CA3233534A1/en active Pending
- 2022-09-30 WO PCT/CN2022/123409 patent/WO2023051802A1/zh not_active Ceased
- 2022-09-30 JP JP2024519557A patent/JP2024534667A/ja active Pending
- 2022-09-30 CN CN202280063875.9A patent/CN118201623A/zh active Pending
- 2022-09-30 KR KR1020247013258A patent/KR20240082366A/ko active Pending
- 2022-09-30 EP EP22875183.0A patent/EP4410296A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8754048B2 (en) | Light-receiving channel rhodopsin having improved expression efficiency | |
| CA2165969A1 (en) | Vertebrate apoptosis gene: compositions and methods | |
| MX2010012592A (es) | Vectores para la administracion de proteinas sensibles a la luz y metodos de uso de las mismas. | |
| JP2024534667A5 (enExample) | ||
| CN112451669A (zh) | Ptbp1抑制剂在预防和/或治疗功能性神经元死亡相关的神经系统疾病中的应用 | |
| US20250115650A1 (en) | Direct transdifferentiation for treatment of neurological disease | |
| JP7428404B2 (ja) | Ｇｓｘ１を使用した脊髄損傷（ｓｃｉ）および脳損傷の処置 | |
| KR102594254B1 (ko) | 운동성 신경세포 직접교차 분화용 인자 | |
| JP7680072B2 (ja) | リプログラミング用機能性断片、組み合わせ、およびその用途 | |
| JP2023540130A5 (enExample) | ||
| WO2021032068A1 (zh) | Ptbp1抑制剂在预防和/或治疗功能性神经元死亡相关的神经系统疾病中的应用 | |
| US20250281648A1 (en) | Use of transdifferentiation of glial cells into neurons in prevention or treatment of diseases associated with neuron loss-of-function or death | |
| AU749530B2 (en) | CNS neuroregenerative compositions and methods of use | |
| JP2023524900A (ja) | 機能性ニューロンへのグリア細胞の分化転換を誘導するための方法、及びその用途 | |
| RS62236B1 (sr) | Rekombinantni dgkk gen za gensku terapiju fragilnog x sindroma | |
| CN115335525B (zh) | 经修饰的通道视紫红质 | |
| CN120093951B (zh) | 一种利用内源性小胶质细胞再生视网膜神经节细胞的组合物及应用 | |
| US20240400984A1 (en) | Treatment of Neuronal Absence Disease by Transdifferentiating Treatment | |
| WO2024245132A1 (en) | Optogenetic activation for signal transduction | |
| WO2025264696A2 (en) | Restorative cell therapy for eye diseases and vision loss | |
| KR20250097002A (ko) | Oct4, Sox2, Klf4 단백질을 포함하는 엔지니어링된 바이러스-유사 입자를 유효성분으로 포함하는 노화의 예방 또는 치료용 약제학적 조성물 | |
| CN120958137A (zh) | 治疗神经系统疾病的表达载体和组合物 | |
| TW202602502A (zh) | 一種胜肽拓印轉染複合物及其用途與製備方法、以及利用胜肽拓印轉染複合物誘導細胞分化為神經細胞之方法 | |
| KR101186218B1 (ko) | 히레귤린 베타1의 ｅｇｆ-성 도메인 펩타이드의 용도 | |
| Ferguson et al. | Intraneuronal determinants of axon regeneration |